TPIDB > Principal Investigator
Principal Investigator
更新時間：2026-10-14
張國軒
- Principal Investigator
- Clinical Trial Experience (year)
Publication
6Publications
1
Lee CH, Juan CH, Chen HH, Hong JP, Liao TW, French I, Lo YS, Want YR, Cheng ML, Wu HC, Chen CM, Chang KH (2025).Long-Range Temporal Correlations in Electroencephalography for Parkinson's Disease Progression, Mov Disord, 40: 266-275
2
Chang KH, Cheng ML, Tang HY, Lin CY, Chen CM (2024). Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington's disease. Aging Cell. 23:e14302.
3
Chang KH, Chen CM, Lin CN, Tsai SS, Lyu RK, Chu CC, Ro LS, Liao MF, Chang HS, Weng YC, Hwang JS, Kuo HC (2024) Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus. J Peripher Nerv Syst. 2023 Dec;28(4):651-663.
4
Chang KH, Liu CH, Wang YR, Lo YS, Chang CW, Wu HC, Chen CM (2023) Upregulation of APAF1 and CSF1R in peripheral blood mononuclear cells of Parkinson's disease. Int. J. Mol. Sci. 12;24(8):7095.
5
Chang CW, Ro LS, Lyu RK, Kuo HC, Liao MF, Wu YR, Chen CM, Chang HS, Weng YC, Huang CC, Chang KH (2022). Establishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning. Muscle Nerve. 66:603-611.
6
Chang KH, Huang CY, Ou-Yang CH, Ho CH, Lin HY, Hsu CL, Chen YT, Chou YC, Chen YJ, Chen Y, Lin JL, Wang JK, Lin PW, Lin YR, Lin MH, Tseng CK, Lin CH (2021). In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation. Stem Cell Res Ther 12(1):508.
